The US Cutaneous Oncodermatology Management (USCOM) project aims to improve cancer patients’ and survivors’ quality of life by offering tools for preventing and managing cancer treatment-related cutaneous toxicities.
The USCOM panel of clinicians who treat cancer treatment-related cutaneous CAEs developed, discussed, and reached a consensus on statements and an evidence-based algorithm supporting prevention, treatment, and maintenance using OTC skincare measures. The algorithm focuses on skincare measures to prevent and treat cutaneous toxicities using prevention measures and a skincare regimen involving hygiene, moisturization, sun protection, and camouflage products. The algorithm aims to improve patient outcomes and sought to determine the best approach for oncology skincare programs for all stakeholders in the US health care setting. These include medical oncologists, family practice/internal medicine physicians, dermatologists, oncology nurses, advanced practice providers (APPs), nurse practitioners (NP), physician assistants (PA), and pharmacists.
SPEAKERS
Mario Lacouture, MD, FAAD
Director
Onco-Dermatology Program
Memorial Sloan Kettering Cancer Center
Professor, Dermatology
Weill Cornell Medicine
New York, New York
Alice Ho, MD, MBA
Radiation Oncologist
Massachusetts General Hospital
Associate Professor
Harvard Medical School
Director of Breast Radiation Oncology
Boston, Massachusetts
HOSTED BY
IN PARTNERSHIP WITH
SUPPORTED BY
